International Biotechnology Trust Balance Sheet Health
Financial Health criteria checks 4/6
International Biotechnology Trust has a total shareholder equity of £270.3M and total debt of £32.5M, which brings its debt-to-equity ratio to 12%. Its total assets and total liabilities are £304.9M and £34.6M respectively.
Key information
12.0%
Debt to equity ratio
UK£32.47m
Debt
Interest coverage ratio | 5.3x |
Cash | n/a |
Equity | UK£270.32m |
Total liabilities | UK£34.55m |
Total assets | UK£304.87m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: IBT's short term assets (£3.0M) do not cover its short term liabilities (£34.6M).
Long Term Liabilities: IBT has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: IBT's net debt to equity ratio (12%) is considered satisfactory.
Reducing Debt: IBT's debt to equity ratio has increased from 0.1% to 12% over the past 5 years.
Debt Coverage: IBT's debt is well covered by operating cash flow (84.1%).
Interest Coverage: IBT's interest payments on its debt are well covered by EBIT (5.3x coverage).